glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with substance p in 1 studies
| Studies (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Trials (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Recent Studies (post-2010) (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Studies (substance p) | Trials (substance p) | Recent Studies (post-2010) (substance p) |
|---|---|---|---|---|---|
| 99 | 1 | 18 | 17,289 | 277 | 2,010 |
| Protein | Taxonomy | glyceraldehyde 3-phosphate dehydrogenase (304-313) (IC50) | substance p (IC50) |
|---|---|---|---|
| Substance-P receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Substance-K receptor | Rattus norvegicus (Norway rat) | 0.2 | |
| Substance-K receptor | Homo sapiens (human) | 0.2455 | |
| Substance-P receptor | Homo sapiens (human) | 0.0011 | |
| Neuromedin-K receptor | Homo sapiens (human) | 0.125 | |
| Substance-K receptor | Mesocricetus auratus (golden hamster) | 0.148 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, P; Fox, KA; Ludlam, CA; Newby, DE; Witherow, FN | 1 |
1 other study(ies) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and substance p
| Article | Year |
|---|---|
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy.
Topics: Aged; Bradykinin; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Peptide Fragments; Plethysmography; Substance P; Tissue Plasminogen Activator; Vasomotor System | 2002 |